头颈部癌症的免疫治疗。
Immunotherapy for Head and Neck Cancer.
机构信息
Department of Oral and Maxillofacial Surgery, The Royal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australia; Department of Oral and Maxillofacial Surgery, Monash Health, 823 Centre Road, Bentleigh East, Victoria 3165, Australia; Oral and Maxillofacial Surgery Unit, Barwon Health, Ryrie Street & Bellerine Street, Geelong, Victoria 3220, Australia.
Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Providence Cancer Institute, 4805 Northeast Glisan Street, Suite 2N35, Portland, OR 97213, USA.
出版信息
Hematol Oncol Clin North Am. 2019 Apr;33(2):301-321. doi: 10.1016/j.hoc.2018.12.006.
The immune system has a vital role in the development, establishment, and progression of head and neck squamous cell carcinoma (HNSCC). Immune evasion of cancer cells leads to progression of HNSCC. An understanding of this mechanism provides the basis for improved therapies and outcomes for patients. Through the tumor's influence on the microenvironment, the immune system can be exploited to promote metastasis, angiogenesis, and growth. This article provides an overview of the interaction between immune infiltrating cells in the tumor microenvironment, and the immunologic principles related to HNSCC. Current immunotherapeutic strategies and emerging results from ongoing clinical trials are presented.
免疫系统在头颈部鳞状细胞癌（HNSCC）的发展、建立和进展中起着至关重要的作用。癌细胞的免疫逃逸导致 HNSCC 的进展。了解这一机制为改善患者的治疗效果和预后提供了基础。通过肿瘤对微环境的影响，可以利用免疫系统促进转移、血管生成和生长。本文综述了肿瘤微环境中免疫浸润细胞的相互作用，以及与 HNSCC 相关的免疫学原理。介绍了当前的免疫治疗策略和正在进行的临床试验的新结果。
Zotero 插件